tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB

Genmab (GMAB) Technical Analysis

460 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Genmab A/S’s (GMAB) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Genmab A/S is a Sell.
Genmab A/S’s (GMAB) 20-Day exponential moving average is 28.88, while Genmab A/S’s (GMAB) share price is $29.16, making it a Buy.
Genmab A/S’s (GMAB) 50-Day exponential moving average is 29.14, while Genmab A/S’s (GMAB) share price is $29.16, making it a Buy.

Genmab (GMAB) Pivot Points

May 14, 2024, 08:12 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
28.51
28.61
28.73
28.83
28.94
29.04
29.15
Fibonacci
28.61
28.69
28.74
28.83
28.91
28.96
29.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genmab (GMAB) Moving Averages

May 14, 2024, 08:12 AM
Period
Simple
Exponential
MA5
28.98Buy
28.96Buy
MA10
28.78Buy
28.86Buy
MA20
28.65Buy
28.88Buy
MA50
29.41Sell
29.14Buy
MA100
29.44Sell
29.84Sell
MA200
31.81Sell
32.34Sell
Genmab A/S’s (GMAB) 10-Day exponential moving average is 28.86, while Genmab A/S’s (GMAB) share price is $29.16, making it a Buy.
Genmab A/S’s (GMAB) 100-Day exponential moving average is 29.84, while Genmab A/S’s (GMAB) share price is $29.16, making it a Sell.
Genmab A/S’s (GMAB) stock price is $29.16 and Genmab A/S’s (GMAB) 50-day simple moving average is 29.41, creating a Sell signal.
Genmab A/S’s (GMAB) stock price is $29.16 and Genmab A/S’s (GMAB) 100-day simple moving average is 29.44, creating a Sell signal.
Genmab A/S’s (GMAB) stock price is $29.16 and Genmab A/S’s (GMAB) 200-day simple moving average is 31.81, creating a Sell signal.

Genmab (GMAB) Technical Indicators

May 14, 2024, 08:12 AM
Name
Value
Implied Action
RSI (14)
51.64
Neutral
STOCH (9,6)
60.73
Neutral
STOCHRSI (14)
60.73
Neutral
MACD (12,26)
-0.09
Sell
ADX (14)
10.78
Buy
Williams %R
-30.35
Buy
CCI (14)
77.27
Neutral
ATR (14)
0.74
-
Ultimate Oscillator
57.90
Neutral
ROC
2.10
Buy
Genmab A/S’s (GMAB) Relative Strength Index (RSI) is 51.64, creating a Neutral signal.
Genmab A/S’s (GMAB) Trend Strength Indicator (ADX) is 10.78, creating a Buy signal.
Genmab A/S’s (GMAB) Commodity Channel Index (CCI) is 77.27, creating a Neutral signal.
Genmab A/S’s (GMAB) Price Rate of Change (ROC) is 2.10, creating a Buy signal.

FAQ

Is GMAB a Buy, Hold, or Sell?
Based on GMAB’s technical indicators, GMAB is a Buy.
    What is GMAB’s RSI (14)?
    GMAB’s RSI (14) is 51.64, which suggests GMAB is a Neutral.
      What is GMAB’s MACD?
      GMAB’s MACD is -0.09, which suggests GMAB is a Sell.
        What is GMAB’s 5-day moving average?
        GMAB’s 5-day moving average is 28.98, which suggests GMAB is a Buy.
          What is GMAB’s 20-day moving average?
          GMAB 20-day moving average is 28.65, which suggests GMAB is a Buy.
            What is GMAB’s 50-day moving average?
            GMAB’s 50-day moving average is 29.41, which suggests GMAB is a Sell.
              What is GMAB’s 200-day moving average?
              GMAB’s 200-day moving average is 31.81, which suggests GMAB is a Sell.
                What is GMAB’s Williams % R (14)?
                GMAB’s Williams % R (14) is -30.35, which suggests GMAB is a Buy.
                  What is GMAB’s CCI (14)?
                  GMAB’s CCI (14) is 77.27, which suggests GMAB is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis